Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25K Buy
225
+100
+80% +$1.04K ﹤0.01% 1497
2025
Q4
$1.26K Sell
125
-106
-46% -$1.01K ﹤0.01% 1065
2025
Q3
$2.07K Buy
231
+106
+85% +$1.02K ﹤0.01% 999
2025
Q2
$1.3K Hold
125
﹤0.01% 1046
2025
Q1
$1.29K Hold
125
﹤0.01% 1064
2024
Q4
$1.19K Hold
125
﹤0.01% 1068
2024
Q3
$1.32K Hold
125
﹤0.01% 1034
2024
Q2
$1.03K Sell
125
-128
-51% -$1.07K ﹤0.01% 1070
2024
Q1
$2.15K Hold
253
﹤0.01% 927
2023
Q4
$2.08K Buy
+253
New +$2.08K ﹤0.01% 907
2023
Q3
Sell
-253
Closed -$2.12K 543
2023
Q2
$2.12K Hold
253
﹤0.01% 882
2023
Q1
$2.06K Sell
253
-225
-47% -$1.79K ﹤0.01% 857
2022
Q4
$3.82K Buy
478
+225
+89% +$1.53K ﹤0.01% 763
2022
Q3
$2K Buy
+253
New +$1.64K ﹤0.01% 806

Other funds holding HLN

CVA Family Office's HLN Position: Q1 2026 in Review

CVA Family Office increased its Haleon (HLN) stake by 80% in Q1 2026, buying an estimated $1.04K and bringing the position to 225 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

CVA Family Office first reported a position in HLN in Q3 2022 and has held it in 14 quarters since. The position peaked at $3.82K in Q4 2022. 619 funds tracked by Wall St. Rank hold HLN as of Q1 2026.

  • CVA Family Office held 225 shares of Haleon worth $2.25K as of Q1 2026.
  • CVA Family Office bought 100 Haleon shares in Q1 2026, an estimated $1.04K.
  • Haleon made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1497 holding.
  • CVA Family Office first reported a position in Haleon in Q3 2022 and has held it in 14 quarters since.
  • CVA Family Office's Haleon position peaked at $3.82K in Q4 2022.
  • 619 funds tracked by Wall St. Rank held Haleon as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.